HSD17B1 Gene Polymorphisms and Risk of Endometrial and Breast Cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 2, 2004, Pages 213-219

  Setiawan, Veronica Wendy ^a   Hankinson, Susan E ^a   Colditz, Graham A ^a   Hunter, David J ^a   De Vivo, Immaculata ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRONE; ESTRONE SULFATE;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HIGH RISK PATIENT; HSD17B1 GENE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; ESTROGENS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; HYDROXYSTEROID DEHYDROGENASES; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RISK ASSESSMENT;

EID: 1242336880     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-03-0241     Document Type: Article

References (14)

1. Henderson, B. E., and Feigelson, H. S. Hormonal carcinogenesis. Carcinogenesis (Lond.), 21: 427-433, 2000.
2. Normand, T., Narod, S., Labrie, F., and Simard, J. Detection of polymorphisms in the estradiol 17β-hydroxysteroid dehydrogenase 2 gene at the EDH17B2 locus on 17q11-q21. Hum. Mol. Genet., 2: 479-483, 1993.
3. Mannermaa, A., Peltoketo, H., Winqvist, R., Ponder, B., Kiviniemi, H., Easton, D., Poutanen, M., Isomaa, V., and Vihko, R. Human familial and sporadic breast cancer: analysis of the coding regions of the 17β-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay. Hum. Genet., 93: 319-324, 1994.
4. Feigelson, H. S., McKean-Cowdin, R., Coetzee, G. A., Stram, D. O., Kolonel, L. N., and Henderson, B. E. Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates. Cancer Res., 61: 785-789, 2001.
5. Wu, A. H., Seow, A., Arakawa, K., Van Den Berg, D., Lee, H. P., and Yu, M. C. HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore. Int. J. Cancer, 104: 450-457, 2003.
6. Hankinson, S. E., Willett, W. C., Manson, J. E., Colditz, G. A., Hunter, D. J., Spiegelman, D., Barbieri, R. L., and Speizer, F. E. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst. (Bethesda), 90: 1292-1299, 1998.
7. Johnson, G. C., Esposito, L., Barratt, B. J., Smith, A. N., Heward, J., Di Genova, G., Ueda, H., Cordell, H. J., Eaves, I. A., Dudbridge, F., Twells, R. C., Payne, F., Hughes, W., Nutland, S., Stevens, H., Carr, P., Tuomilehto-Wolf, E., Tuomilehto, J., Gough, S. C., Clayton, D. G., and Todd, J. A. Haplotype tagging for the identification of common disease genes. Nat. Genet., 29: 233-237, 2001.
8. Luu-The, V., Labrie, C., Simard, J., Lachance, Y., Zhao, H. F., Couet, J., Leblanc, G., and Labrie, F. Structure of two in tandem human 17 β-hydroxysteroid dehydrogenase genes. Mol. Endocrinol., 4: 268-275, 1990.
9. Qin, Z. S., Niu, T., and Liu, J. S. Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am. J. Hum. Genet., 71: 1242-1247, 2002.
10. Haiman, C. A., Hankinson, S. E., Spiegelman, D., Colditz, G. A., Willett, W. C., Speizer, F. E., Kelsey, K. T., and Hunter, D. J. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res., 59: 1015-1020, 1999.
11. Hankinson, S. E., Manson, J. E., Spiegelman, D., Willett, W. C., Longcope, C., and Speizer, F. E. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol. Biomark. Prev., 4: 649-654, 1995.
12. De Vivo, I., Huggins, G. S., Hankinson, S. E., Lescault, P. J., Boezen, M., Colditz, G. A., and Hunter, D. J. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc. Natl. Acad. Sci. USA, 99: 12263-12268, 2002.
13. De Vivo I., Hankinson S. E., Colditz, G. A., and Hunter D. J. A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. Cancer Res., 63: 5236-5238, 2003.
14. Puranen, T., Poutanen, M., Peltoketo, H., Vihko, P., and Vihko, R. Site-directed mutagenesis of the putative active site of human 17γ-hydroxysteroid dehydrogenase type 1. Biochem. J., 304: 289-293, 1994.